Dendright

Ultragenyx Pharmaceutical Inc. unveiled positive 14-month data on 11 June from the Phase II portion of a potentially registrational trial of setrusumab in osteogenesis imperfecta (OI), which multiple

Over the past five years, Johnson & Johnson Innovation LLC has inked more than 300 deals, the group’s top executive said in an interview with Scrip , and continues to refine its focus on identifyin

Under an R&D collaboration and option and licensing agreement with Modern Biosciences PLC , Janssen Biotech Inc. is seeking to bolster its rheumatoid arthritis franchise with small-molecule can

IN VITRO DIAGNOSTICS Abcodia Ltd. Massachusetts General Hospital University of London Queen Mary, University of London Abcodia licenses proprietary ovarian cancer risk algorithm from MGH , Univ.